Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.

CME information and select publications here.